Le Lézard
Classified in: Health, Science and technology
Subject: CHI

SpringCM, a DocuSign Company, Announces #DreamWithJames Social Media Campaign to Raise Awareness for Curing Childhood Disease


SAN FRANCISCO, Sept. 21, 2018 /PRNewswire/ -- SpringCM, a DocuSign company, today announced that it has launched a social media campaign to raise money for New Genes, a not-for-profit organization dedicated to gene replacement therapy to address terminal childhood diseases. The campaign runs during Dreamforce 2018, the most innovative software conference of the year.

SpringCM is promoting the campaign across social media, including releasing a series of videos and Tweets with the hashtag #DreamWithJames. Every time someone tweets or retweets the hashtag, SpringCM donates one dollar to New Genes.

Last year, James Serra, DocuSign's Social Media Marketing Specialist, shared his dream of meeting Marc Benioff and getting a selfie with him. He accomplished that and a donation was made to the UCSF Benioff Children's Hospitals in honor of that achievement. This year, James is again featured in campaign videos as he seeks to meet all of the Dreamforce keynote speakers, as well as the musical act performing at Dreamforce 2018. If he meets the band and gets onstage to promote the charitable donation, SpringCM will double the donation amount.

Comments on the News

SpringCM and DocuSign are Platinum Sponsors at Dreamforce 2018, which takes place in San Francisco from September 25-28. SpringCM and DocuSign are exhibiting at booths 1118 and 1128 in the Dreamforce Customer Success Expo, showcasing the launch of the Modern System of Agreement platform, enabling you to accelerate and simplify how you prepare, sign, enact and manage agreements.

In addition, SpringCM and DocuSign will be speaking on the Rise of Modern Systems of Agreement at the following times during Dreamforce:

Tuesday, September 25th

Wednesday, September 26th

Thursday, September 27th

Salesforce, Dreamforce and others are among the trademarks of salesforce.com, inc.

About DocuSign, Inc.
DocuSign helps organizations connect and automate how they prepare, sign, act-on, and manage agreements. As part of its cloud-based System of Agreement Platform, DocuSign offers eSignature?the world's #1 way to sign electronically on practically any device, from almost anywhere, at any time. Today, more than 425,000 customers and hundreds of millions of users in over 180 countries use DocuSign to accelerate the process of doing business and simplify people's lives.

For more information, visit www.docusign.com, call +1-877-720-2040, or follow @DocuSign on Twitter, LinkedIn, Facebook, Instagram and Snapchat.

Copyright 2003-2018. DocuSign, Inc. is the owner of DOCUSIGN® and all of its other marks (www.docusign.com/IP). All other marks appearing herein are the property of their respective owners.

 

SOURCE SpringCM


These press releases may also interest you

at 16:55
Global design company, West Elm, a portfolio brand of Williams-Sonoma, Inc. , the world's largest digital-first, design-led and sustainable home retailer, announced today the launch of a new mobile iOS design and shopping app. Developed with the...

at 16:35
Today Domo announced at Domopalooza: the AI + Data Conference enhancements to Cloud Amplifier, the company's multi-cloud data offering, to enable users with the powerful and flexible tools they need to fully integrate with multiple cloud data...

at 16:30
Nuvve Holding Corp. (Nuvve) , a green energy technology company that provides a globally-available, commercial vehicle-to-grid (V2G) technology platform designed to enable electric vehicle (EV) batteries to store and resell unused energy back to the...

at 16:28
The Rett Syndrome Research Trust (RSRT) is proud to announce its partnership with PMD Solutions, a leading provider of innovative healthcare technologies, in their upcoming biosensor validation study called VIBRANT. PMD Solutions will generously...

at 16:25
Fortive Corporation ("Fortive") today announced that it will webcast its earnings conference call for the first quarter 2024 on Wednesday, April 24, 2024 beginning at 12:00 p.m. ET and lasting approximately 1 hour. The call and an accompanying...

at 16:20
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced business updates and financial results for the fourth quarter and full year ended December 31,...



News published on and distributed by: